Skip to main content
Clinical Trials/ISRCTN12471415
ISRCTN12471415
Completed
Not Applicable

Effectiveness of patient support programme for the treatment of hepatitis C

Department of Health (Taiwan)0 sites500 target enrollmentJune 2, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Health (Taiwan)
Enrollment
500
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 2, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Health (Taiwan)

Eligibility Criteria

Inclusion Criteria

  • Adult patients who have never received interferon and who had at least 2000 copies of HCV ribonucleic acid per ml (RNA/ml) of serum with polymerase chain reaction (PCR) assay, serum aspartate aminotransferase (AST) above the upper limit of normal within six months before entry into study and a liver biopsy result consistent with the diagnosis of chronic hepatitis C.

Exclusion Criteria

  • Patients with:
  • 1\. Neutropenia (\<1500/ml of neutrophils)
  • 2\. Anemia (Hb \<12g/dl of hemoglobin)
  • 3\. Thrombocytopenia (platelet \<90000/ml)
  • 4\. Human immunodeficiency virus (HIV) infection
  • 5\. Decompensated liver disease
  • 6\. Serum creatinine \>1\.5 times the upper limit of normal
  • 7\. Poorly\-controlled psychiatric disease
  • 8\. Unwilling to receive contraception

Outcomes

Primary Outcomes

Not specified

Similar Trials